Latent Health Raises $80M in Series A to Expand Clinical AI Platform
Funding Details
$80M
Series A
Healthcare doesn’t fail in the operating room, it stalls in the in-between. The space where decisions are made, then buried under layers of approvals, forms, and polite delays that quietly cost real outcomes. Latent Health looked at that dead space and said, nah, we’re not waiting on hold.
Rishabh Jain (CEO) and Sriram Somasundaram built Latent Health with a simple but dangerous idea: what if clinical intelligence didn’t stop at the doctor’s note, but carried all the way through to actually getting patients the medication they need. Not theory. Not dashboards. Execution. The kind that moves at machine speed but thinks in clinical context.
That vision just pulled in an $80M Series A, led by Spark Capital and Transformation Capital, with Conviction, McKesson Ventures, General Catalyst, and Y Combinator all leaning in. Smart money doesn’t chase noise, it follows signal. And this one’s loud in all the right ways.
Here’s the part most people miss. Prior authorization isn’t just paperwork, it’s a gatekeeper disguised as admin. Latent Health turns that friction into flow, embedding directly into the EHR, reading the chart like a seasoned clinician, matching it against payer logic, and pushing the process forward without the usual back-and-forth theater.
More than 45+ health systems are already on board. Half of the top 20 in the U.S. are in the mix. Over 2M patients are seeing faster access to therapy, and medication denials are dropping by more than 30% in many cases. That’s not optimization, that’s impact you can measure in real outcomes, not just cleaner workflows.
And here’s where it gets interesting. This isn’t just about speed, it’s about leverage. When clinicians can serve 2x as many patients in the same window, you’re not just improving systems, you’re expanding capacity without adding headcount. In a market where specialty drugs alone represent a $200B opportunity, that kind of efficiency isn’t nice to have, it’s survival.
The real play is the Clinical Reasoning Engine underneath it all. Not automation for automation’s sake, but software that actually understands why a decision should happen, then makes sure it does. Hospitals, payers, pharmacies, patients, all finally speaking the same language, without needing a translator on every call.









